L-Carnitine transport in human placental brush-border membranes is mediated by the sodium-dependent organic cation transporter OCTN2

被引:67
作者
Lahjouji, K
Elimrani, I
Lafond, J
Leduc, L
Qureshi, IA
Mitchell, GA
机构
[1] Univ Montreal, Hop St Justine, Div Med Genet, Montreal, PQ H3T 1C5, Canada
[2] Univ Quebec, Dept Sci Biol, Lab Physiol Maternofaetale, Montreal, PQ H3C 3P8, Canada
[3] Hop St Justine, Dept Obstet & Gynecol, Montreal, PQ H3T 1C5, Canada
来源
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY | 2004年 / 287卷 / 02期
关键词
membrane transport; valproate; maternofetal; xenobiotics; acylcarnitine;
D O I
10.1152/ajpcell.00333.2003
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Maternofetal transport of L-carnitine, a molecule that shuttles long-chain fatty acids to the mitochondria for oxidation, is thought to be important in preparing the fetus for its lipid-rich postnatal milk diet. Using brush-border membrane (BBM) vesicles from human term placentas, we showed that L-carnitine uptake was sodium and temperature dependent, showed high affinity for carnitine (apparent K-m = 11.09 +/- 1.32 muM; V-max = 41.75 +/- 0.94 pmol.mg protein(-1).min(-1)), and was unchanged over the pH range from 5.5 to 8.5. L-Carnitine uptake was inhibited in BBM vesicles by valproate, verapamil, tetraethylammonium, and pyrilamine and by structural analogs of L-carnitine, including D-carnitine, acetyl-D, L-carnitine, and propionyl-, butyryl-, octanoyl, isovaleryl-, and palmitoyl-L-carnitine. Western blot analysis revealed that OCTN2, a high-affinity, Na+-dependent carnitine transporter, was present in placental BBM but not in isolated basal plasma membrane vesicles. The reported properties of OCTN2 resemble those observed for L-carnitine uptake in placental BBM vesicles, suggesting that OCTN2 may mediate most maternofetal carnitine transport in humans.
引用
收藏
页码:C263 / C269
页数:7
相关论文
共 48 条
[1]  
Campistol J, 2000, REV NEUROLOGIA, V30, pS105
[2]   Functional characterization of intestinal L-carnitine transport [J].
Durán J.M. ;
Peral M.J. ;
Calonge M.L. ;
Ilundáin A.A. .
The Journal of Membrane Biology, 2002, 185 (1) :65-74
[3]   Expression and localization of organic cation/carnitine transporter OCTN2 in Caco-2 cells [J].
Elimrani, I ;
Lahjouji, K ;
Seidman, E ;
Roy, MJ ;
Mitchell, GA ;
Qureshi, I .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2003, 284 (05) :G863-G871
[4]   β-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter [J].
Ganapathy, ME ;
Huang, W ;
Rajan, DP ;
Carter, AL ;
Sugawara, M ;
Iseki, K ;
Leibach, FH ;
Ganapathy, V .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (03) :1699-1707
[5]   THE DEVELOPMENT OF CARNITINE SYNTHESIS FROM GAMMA-BUTYROBETAINE IN THE RAT [J].
HAHN, P .
LIFE SCIENCES, 1981, 28 (09) :1057-1060
[6]   Characteristics of L-lactic acid transport in basal membrane vesicles of human placental syncytiotrophoblast [J].
Inuyama, M ;
Ushigome, F ;
Emoto, A ;
Koyabu, N ;
Satoh, S ;
Tsukimori, K ;
Nakano, H ;
Ohtani, H ;
Sawada, Y .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2002, 283 (03) :C822-C830
[7]   Transplacental treatment of fetal tachycardia: Implication of drug transporting proteins in placenta [J].
Ito, S .
SEMINARS IN PERINATOLOGY, 2001, 25 (03) :196-201
[8]  
KEMPSON SA, 1979, AM J PHYSIOL, V237, pE465, DOI 10.1152/ajpendo.1979.237.5.E465
[9]  
Kozma C, 2001, AM J MED GENET, V98, P168, DOI 10.1002/1096-8628(20010115)98:2<168::AID-AJMG1026>3.0.CO
[10]  
2-O